Becky Mccall

VIENNA, Austria — The appropriate dose of pancreatic enzyme replacement therapy (PERT) for exocrine pancreatic insufficiency (EPI) depends on the

A diet high in ultraprocessed foods can raise the relapse risk in patients with Crohn’s disease who are in remission, with some subgroups of those foods increasing that risk approximately threefold.

VIENNA — A diet high in ultraprocessed foods (UPFs) increases the risk for clinical relapse in patients with Crohn's disease (CD) who are in remission, results of a new study suggested.

Interim phase 3 results showed the IL-13 monoclonal antibody improves histology and symptoms in EoE, even in participants with inadequate response or intolerance to steroids.

VIENNA — Cendakimab, a monoclonal antibody targeting interleukin (IL) 13, improved symptoms and reduced esophageal eosinophil counts in adult and

VIENNA — Researchers have determined a bidirectional relationship between inflammatory bowel disease (IBD) and type 1 diabetes (T1D), using both a cohort and case-control approach to analysis.

VIENNA — The effectiveness of computer-aided diagnosis (CADx) in differentiating neoplastic from non-neoplastic polyps depends on the region of the colon examined, according to a systematic review and meta-analysis.

VIENNA — Cendakimab, a monoclonal antibody targeting interleukin (IL) 13, improved symptoms and reduced esophageal eosinophil counts in adult and adolescent patients with eosinophilic esophagitis (EoE), according to interim results of a pivotal phase 3 trial.

VIENNA — A diet high in ultraprocessed foods (UPFs) increases the risk for clinical relapse in patients with Crohn’s disease (CD) who are in remission, results of a new study suggested.

VIENNA — Guselkumab has been shown to be efficacious vs placebo in patients with moderately to severely active Crohn’s disease (CD), regardless of prior biologic therapy exposure, according to a pooled analysis of the two phase 3 double-blind GALAXI 2 and 3 studies.